Case Study
Digital transformation of clinical trials.
Partnering with Hexaware, a global CRO digitally transformed clinical trials—achieving $1.02M in cost savings, 80% less document time, 2x patient onboarding, and 25% improved reporting.
The client is the world’s largest clinical research organization that offers technology solutions, advanced analytics, and clinical research services to the life sciences industry, leveraging its vast expertise and resources to foster intelligent connections in healthcare.
In the wake of the global COVID-19 crisis, the clinical trials landscape faced unprecedented challenges that demanded immediate transformation. While many hesitated to embrace the digital era, our client stood among the visionary few who recognized the urgency of turning these existential threats into groundbreaking opportunities.
The client wanted to digitally transform their clinical trials infrastructure, modernize and streamline their clinical trial processes, and embrace digital solutions to enhance efficiency and effectiveness in the face of evolving global challenges.
Hexaware successfully enabled a virtual clinical trial platform in three stages. They included:
Stage 1: Trial Design
Hexaware initiated the process by creating a robust trial design platform, providing essential data and insights to facilitate an efficient design. We leveraged Salesforce technologies to enhance and support the new trial design platform.
Stage 2: Trial Start-Up
This phase focused on three key areas:
Stage 3: Trial Conduct & Closure
This stage involved the following key initiatives:
The solution yielded the following transformative benefits for the client:
In partnership with Hexaware, the world’s largest CRO embraced digital transformation in clinical trials. The three-stage virtual trial solution delivered remarkable outcomes: a 30% enhancement in clinical design efficiency, $1.02 million in cost savings, an 80% reduction in document processing time, a twofold acceleration in patient recruitment, 25% increased patient onboarding, and a 25% improvement in reporting efficiency. This transformation helped the client to tackle the global challenges related to COVID-19 and reshaped the clinical trials landscape.